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Thomas Chalmers, vitamin C and the
common cold
Kay Dickersin and Frances Chalmers1 wrote that
Thomas Chalmers ‘contributed substantially to the
wave of meta-analyses in medicine which took oﬀ
during the late 1970s and 1980s’. Chalmers’ meta-
analysis on vitamin C and the common cold2 was
mentioned as an example of the studies that provided
statistically more robust estimates of treatment
eﬀects, but that is an unfortunate example.
In his 1975 meta-analysis, Thomas Chalmers cal-
culated of seven placebo-controlled trials that
common cold episodes were 0.11 0.24 (SE) days
shorter for the vitamin C groups than for the placebo
groups.2
I showed in 1995 that in some cases Chalmers pre-
sented data that were inconsistent with the original
data. Chalmers also made errors in the calculations
and ignored the doses, and his selection of trials was
inconsistent.3 I analysed the studies Chalmers had
identiﬁed for which 1 g/d of vitamin C had been
used and calculated that common cold episodes
were 0.93 0.22 (SE) days shorter in the vitamin C
groups. Another measure of the eﬀect was a
21% 3% (SE) reduction in the cold duration.3
Thomas Chalmers speculated that the beneﬁt of
vitamin C seen in some trials might be explained by
the placebo eﬀect.2 His suggestion was based on the
Karlowski et al.’s trial,4 for which Chalmers was
the principal investigator and about which he
stated in 1996: ‘I am more proud of it than
almost any other that I have published’.5 I
showed in 1996 that the Karlowski trial was erro-
neously analysed, however.5
Chalmers’ meta-analysis and Karlowski’s trial lar-
gely quelled interest in vitamin C, and few trials have
been carried out since the late 1970s.6 In any case,
there is now very strong evidence that 1 g/d of vita-
min C shortens the mean duration of colds in children
by 18% and in adults by 8%.6
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